A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/138 (2006.01) A61K 31/343 (2006.01) A61K 31/353 (2006.01) A61K 31/437 (2006.01) A61K 31/4409 (2006.01) A61K 31/4412 (2006.01) A61K 31/496 (2006.01) A61K 31/5377 (2006.01) A61K 31/551 (2006.01) A61P 27/06 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2506464
It is intended to establishing the usefulness as a remedy for glaucoma of a combination of an Rho kinase inhibitor, which has a novel function mechanism, with a .beta.-blocker. By combining the Rho kinase inhibitor with the .beta.- blocker, the effects of lowering ocular tension of these compounds can be complemented and/or potentiated each other. Concerning the administration form, they can be administered either combinedly or as a mixed preparation.
L'objectif de l'invention est de démontrer l'utilité thérapeutique d'une association comprenant un inhibiteur de la Rho-kinase, possédant un nouveau mécanisme de fonctionnement, et un bêtabloquant pour traiter le glaucome. Grâce à l'association de l'inhibiteur de la Rho-kinase et du bêtabloquant, les effets de réduction de la tension oculaire produits par ces composés peuvent se compléter et/ou se potentialiser. Ces composés peuvent être administrés de façon combinée ou sous la forme d'une préparation mixte.
Hara Hideaki
Hatano Masakazu
Matsugi Takeshi
Nakajima Tadashi
Fetherstonhaugh & Co.
Santen Pharmaceutical Co. Ltd.
LandOfFree
Therapeutic agent for glaucoma comprising rho kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for glaucoma comprising rho kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for glaucoma comprising rho kinase... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1791241